June 22, 2020 – Biocare Medical, a leading provider of innovative, automated immunohistochemistry (IHC) reagents, instrumentation and detection systems has been mentioned in a recent early release study by the Centers for Disease Control: Pathology and Pathogensis of SARS-CoV-2 Associated with Fatal Corona Virus Disease. The ongoing pandemic of the novel coronavirus disease (COVID-19), as […]
Thinking of Automating Your IHC Lab? Are you thinking about automating your IHC Lab? Do you want to increase daily throughput and volume of your lab? Do you need to standardize your staining procedures to reduce variability and improve staining quality? Do you need to reduce hands-on time, decrease cost per slide and better utilize […]
Focus on Concentrates for Flexibility in Your Laboratory Working with antibody concentrates can seem intimidating to new users. However, regular users of concentrated antibodies quickly find that they are both easy to use and offer great advantages. While ready-to-use antibody formats come pre-diluted to a set concentration, antibody concentrates can be titered to any desired […]
Last Updated: March 16, 2020, 5:00 PM PST Dear Biocare Customers, Biocare Medical has been closely monitoring developments around the news of the novel coronavirus (COVID-19). Our COVID-19 preparedness is part of a Company-wide business continuity program. The goal of our planning is to enable Biocare to support our customers’ needs with a minimal level […]
February 13, 2020 – Biocare Medical, a leading provider of innovative, automated immunohistochemistry (IHC) reagents and instrumentation, announces the launch of seven novel IVD IHC antibody markers for clinical diagnostics and research applications.The most recent launch focuses on several immuno-oncology markers, critical in aiding early-stage cancer drug developments and patient treatment. Biocare re-developed a major […]
New p16 INK4a [BC42] monoclonal antibody with exceptional sensitivity and specificity San Francisco, CA, September 3, 2019 – Biocare Medical, LLC, a leading provider of innovative, automated immunohistochemistry (IHC) instrumentation and reagents, announces the release of a new mouse monoclonal antibody, p16 INK4a, for in vitro diagnostic (IVD) use in the qualitative identification of the […]
Approximately 12,000 men and women in the United States are diagnosed with gallbladder cancer annually, leading to an annual estimated 4,000 deaths.1 Gallbladder and other biliary cancers are comparatively rare in the United States, with about 0.7% of new cancer cases classified as gallbladder, contributing approximately 0.6% of cancer deaths yearly.1 Worldwide, gallbladder and other […]
The VALENT, the Market’s Only Open, Fully Automated IVD Platform that Delivers Industry-Leading Throughput and Quality to Clinical, Pharmaceutical and Research Customers San Francisco, CA, January 24, 2019 – Biocare Medical, LLC, a leading provider of innovative, automated immunohistochemistry (IHC) instrumentation and reagents, announces the release of the VALENT IVD (in vitro diagnostic) automated staining […]
Approximately 13,000 women in the United States are diagnosed with cervical cancer annually, leading to an annual estimated 4,000 deaths.1 Cervical cancers are comparatively rare in the United States, with about 0.8% of new cancer cases classified as cervical, contributing approximately 0.7% of cancer deaths yearly.1 Worldwide, cervical cancer is the fourth most frequently diagnosed […]
Formalin has been used since 1893 as the standard fixative for tissue processing in histopathology.1 Due to formalin’s superior preservation of morphological detail, criteria for pathological diagnoses have been established through the observation of formalin-fixed, paraffin-embedded (FFPE) tissue sections stained with hematoxylin and eosin. Although many other fixatives exist, none have supplanted formalin in general […]